| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.00023 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.00015 | 1 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.00013 | 1 |